In this episode of the Gillett Health Podcast, James O'Hara, NP , breaks down the latest evidence surrounding
GLP-1 receptor agonists (like semaglutide) and their potential role in Alzheimer's disease and long-term
cognitive health.
While recent clinical trial results show that oral semaglutide does not reverse established Alzheimer...